Harding Loevner LP Repligen Corp Transaction History
Harding Loevner LP
- $15.7 Billion
- Q1 2024
A detailed history of Harding Loevner LP transactions in Repligen Corp stock. As of the latest transaction made, Harding Loevner LP holds 659,414 shares of RGEN stock, worth $98.3 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
659,414
Previous 716,299
7.94%
Holding current value
$98.3 Million
Previous $129 Million
5.83%
% of portfolio
0.77%
Previous 0.74%
Shares
8 transactions
Others Institutions Holding RGEN
# of Institutions
522Shares Held
53.2MCall Options Held
1.05MPut Options Held
228K-
Black Rock Inc. New York, NY7.77MShares$1.16 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$760 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$532 Million0.08% of portfolio
-
State Street Corp Boston, MA1.76MShares$262 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.46MShares$218 Million0.31% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.27B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....